Qiagen N.V. (QGEN) Rolls Out QIAstat-Dx Rise, Expands U.S. Testing Access
Qiagen N.V.
Qiagen Nv (QGEN)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,032,249 | $49,570,388 | -7% | 0.06% |
| 2. | Millennium Management Israel Englander | 808,562 | $38,859,490 | +490% | 0.02% |
| 3. | Parkman Healthcare Partners Greg Martinez | 498,107 | $23,939,022 | +39% | 2.75% |
| 4. | Citadel Investment Group Ken Griffin | 400,819 | $19,263,361 | -53% | 0% |
| 5. | Balyasny Asset Management Dmitry Balyasny | 326,141 | $15,674,336 | -17% | 0.02% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 23,940,960 | $1,069,682,093 | 0.33% | |
| 2. | 2,874,356 | $133,140,170 | 0.21% | |
| 3. | 2,334,083 | $103,371,531 | 0.17% | |
| 4. | 909,705 | $40,645,607 | 0.01% | |
| 5. | 668,860 | $29,884,665 | 0.08% |
News See All
13 Most Oversold Healthcare Stocks So Far in 2025
The healthcare innovation landscape in 2025 is navigating a complex mix of challenges and opportunities, marked by contrasting trends in fundraising, investment, and technology adoption.
7 Hot Healthcare Stocks to Buy Right Now
The majority of Americans have experienced the annoyance of having their health insurance rejected, frequently without any recourse after contacting carriers by email and phone. Dr.
Qiagen N.V. (NYSE:QGEN) Q2 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. I am Katie, your Global Meet call operator. Welcome, and thank you for joining QIAGEN'S Q2 2025 Earnings Conference Call Webcast.
Qiagen Teams With Gencurix to Expand Digital PCR Cancer Assays
Qiagen N.V. (NYSE:QGEN) ranks among the best CRISPR stocks to buy. Qiagen N.V.
Top 10 CRISPR Stocks to Buy Now
Innovation is a hallmark of the biopharmaceutical sector, which is fueled by the demand for novel therapies to address unresolved medical needs.
Qiagen and ID Solutions Partner to Enhance Digital PCR Assays for Oncology Research
On Friday, Qiagen (NYSE:QGEN) announced a new commercial collaboration and joint marketing agreement with French company ID Solutions to expand the availability of digital polymerase chain reaction (dPCR...
Qiagen N.V. (NYSE:QGEN) Q1 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. I'm Lisa, your PGI call operator. Welcome, and thank you for joining Qiagen's Q1 2025 Earnings Conference Call Webcast.
Hedge Fund Resource Center Billionaire Hedge Funds
